Parallel Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History

Parallel Advisors, LLC

  • $4.31 Billion
  • Q1 2025

A detailed history of Parallel Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 43 shares of AUPH stock, worth $350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 43 -0.0%
Holding current value
$350
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$6.75 - $10.44 $290 - $448
43 New
43 $0
Q4 2023

Feb 09, 2024
BUY
$7.13 - $9.49 $85 - $113
12 New
12 $0
Q2 2021

Aug 06, 2021
SELL
$10.0 - $14.52 $21,500 - $31,218
-2,150 Closed
0 $0
Q1 2021

Apr 23, 2021
SELL
$12.3 - $18.73 $24,600 - $37,460
-2,000 Reduced 48.19%
2,150 $28,000
Q4 2020

Feb 02, 2021
BUY
$12.94 - $16.05 $52,795 - $65,484
4,080 Added 5828.57%
4,150 $57,000
Q3 2020

Oct 27, 2020
BUY
$13.19 - $16.66 $923 - $1,166
70 New
70 $1,000
Q4 2019

Jan 30, 2020
SELL
$3.88 - $21.42 $9,700 - $53,550
-2,500 Closed
0 $0
Q3 2019

Nov 01, 2019
BUY
$5.34 - $6.59 $2,670 - $3,295
500 Added 25.0%
2,500 $13,000
Q4 2018

Feb 05, 2019
BUY
$5.08 - $6.83 $5,080 - $6,830
1,000 Added 100.0%
2,000 $13,000
Q3 2018

Nov 01, 2018
BUY
$5.27 - $6.64 $2,635 - $3,320
500 Added 100.0%
1,000 $7,000
Q2 2018

Jul 30, 2018
SELL
$5.06 - $6.36 $7,589 - $9,540
-1,500 Reduced 75.0%
500 $2,000
Q1 2018

May 08, 2018
SELL
$4.85 - $5.99 $14,549 - $17,970
-3,000 Reduced 60.0%
2,000 $10,000
Q4 2017

Feb 13, 2018
BUY
$4.53 - $7.09 $13,590 - $21,270
3,000 Added 150.0%
5,000 $23,000
Q3 2017

Nov 15, 2017
BUY
$5.71 - $6.9 $11,420 - $13,800
2,000 New
2,000 $11,000
Q3 2017

Nov 14, 2017
SELL
$5.71 - $6.9 $28,550 - $34,500
-5,000 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
5,000
5,000 $32,000

Others Institutions Holding AUPH

# of Institutions
239
Shares Held
64.9M
Call Options Held
1.1M
Put Options Held
772K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.16B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email